Pulmonx (LUNG) Current Deferred Revenue (2019 - 2025)
Pulmonx's (LUNG) quarterly Current Deferred Revenue came in at $100000.0 in Q4 2025, down 25.93% year-on-year from $135000.0 in Q4 2024, and up 8.7% on a QoQ basis from $92000.0 in Q3 2025.
Pulmonx (LUNG) Current Deferred Revenue (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Current Deferred Revenue data on file, last reported at $100000.0 in Q4 2025.
- On a quarterly basis, Current Deferred Revenue fell 25.93% year-over-year to $100000.0 in Q4 2025; TTM through Dec 2025 was $100000.0, a 25.93% decrease from a year earlier, with the FY2025 full-year figure at $100000.0, down 25.93% from the prior year.
- Current Deferred Revenue for Q4 2025 stood at $100000.0, up from $92000.0 in the prior quarter.
- Over the last five years, Current Deferred Revenue for LUNG reached as high as $200000.0 in Q3 2021 and fell as low as $92000.0 in Q3 2025.
- Historically, Current Deferred Revenue has averaged $113400.0 across 5 years, with a median of $100000.0 in 2021.
- Across the five-year window, Current Deferred Revenue surged 100.0% in 2021 and slumped 50.0% in 2022, its largest moves.
- Year by year, Current Deferred Revenue stood at $200000.0 in 2021, then sank by 40.0% to $120000.0 in 2022, then retreated by 13.33% to $104000.0 in 2023, then increased by 29.81% to $135000.0 in 2024, then retreated by 25.93% to $100000.0 in 2025.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $100000.0 in Q4 2025, $92000.0 in Q3 2025, and $100000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Pulmonx | 49.94 Mn | -19.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 92,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 135,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Mar 31, 2024 | 110,000.00 |
| Dec 31, 2023 | 104,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 120,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 100,000.00 |
| Mar 31, 2021 | 100,000.00 |